Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D supplementation and hepatitis B vaccine response in hemodialysis patients
2011-004621-26Phase 3Completed
- Sponsor
- Medical University of Graz
- Start
- May 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of vitamin d in Vitamin D deficiency (VDD) and hepatitis B (HBV), sponsored by Medical University of Graz. Primary endpoint: Anti-HBs antibody level change. Started May 2012; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)hepatitis B (HBV)
Beyond the preview
Go deeper on 2011-004621-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004621-26.